文献速递妇科

微创子宫肌瘤剔除术:大型整合医疗系统内的实践趋势及黑人女性与非黑人女性之间的差异

Minimally invasive myomectomy: practice trends and differences between Black and non-Black women within a large integrated healthcare system.
PubMed 文献 · Am J Obstet Gynecol · 2022-01-31

本研究在Kaiser Permanente北加州系统内回顾性分析了2009至2019年4033例因子宫平滑肌瘤行子宫肌瘤剔除术的成年女性,微创手术比例从6.0%升至89.5%,但黑人女性微创比例持续低于非黑人女性(54.5% vs 64.7%),种族和肌瘤重量不能完全解释差异。

要点

  • 微创子宫肌瘤剔除术比例11年间从6.0%升至89.5%,肌瘤剔除术发生率从0.12/1000升至0.25/1000。
  • 黑人女性微创比例低于非黑人女性(54.5% vs 64.7%),且黑人女性更年轻、肌瘤更重、BMI更高。
  • 2016-2019年手术及高手术量术者与微创比例增加相关,黑人种族和肌瘤重量>500g独立降低微创率。

核心结论

  • 在整合医疗系统内,鼓励微创手术的举措与微创子宫肌瘤剔除术比例显著增加相关,但黑人女性接受微创手术的可能性仍低于非黑人女性。
  • 种族和肌瘤重量本身不能解释微创子宫肌瘤剔除术的差异。

研究设计与样本

  • 回顾性队列研究,纳入2009至2019年在Kaiser Permanente北加州系统内因子宫平滑肌瘤行子宫肌瘤剔除术的≥18岁女性,共4033例。
  • 采用广义估计方程和Cochran-Armitage检验评估肌瘤剔除术发生率及手术路径比例线性趋势,多变量logistic回归评估手术路径与种族/民族及并发症的关联。

主要发现

  • 肌瘤剔除术发生率从2009年的0.12(95%CI 0.12-0.13)/1000女性增至2019年的0.25(95%CI 0.24-0.25)/1000女性(P<.001)。
  • 微创子宫肌瘤剔除术比例从6.0%增至89.5%(增加15倍)。
  • 黑人女性微创比例低于非黑人女性(54.5% vs 64.7%;P<.001)。
  • 黑人女性较非黑人女性更年轻(36.4±5.6 vs 37.4±5.8岁;P<.001)、平均肌瘤重量更高(436.0±505.0 vs 324.7±346.1 g;P<.001)、平均BMI更高(30.8±7.3 vs 26.6±5.9 kg/m2;P<.001)。
  • 2016-2019年手术较2009-2012年手术及高手术量术者较低手术量术者与微创比例增加相关(调整相对危险度分别为12.58 [95%CI 9.96-15.90]和6.63 [95%CI 5.35-8.21])。

关键数值与推荐

  • 黑人种族和肌瘤重量>500g各自独立与较低微创子宫肌瘤剔除术率相关。
  • 种族与肌瘤重量存在交互作用:肌瘤重量≤500g的黑人女性较≤500g的非黑人女性微创可能性更低(调整相对危险度0.74 [95%CI 0.58-0.95]),>500g的黑人女性也较≤500g的非黑人女性更低(调整相对危险度0.26 [95%CI 0.18-0.36])。
  • 控制种族、年龄、肌瘤重量、产次、低收入居住、BMI、术者手术量和手术年份后,开腹与微创子宫肌瘤剔除术的并发症风险无显著差异。
  • 腹腔镜微创较机器人辅助微创者发生任何医疗并发症的风险更低(调整相对危险度0.27;95%CI 0.09-0.83;P=.02)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although multiple professional organizations encourage minimally invasive surgical approaches whenever feasible, nationally, fewer than half of myomectomies are performed via minimally invasive routes. Black women are less likely than their non-Black counterparts to have minimally invasive surgery. OBJECTIVE: This study aimed to assess the trends in surgical approach among women who underwent minimally invasive myomectomies for uterine leiomyomas within a large integrated healthcare system as initiatives were implemented to encourage minimally invasive surgery, particularly evaluating differences in the proportion of minimally invasive surgery performed in Black vs non-Black women. STUDY DESIGN: We conducted a retrospective cohort study of women, aged ≥18 years, who underwent a myomectomy for a uterine leiomyoma within Kaiser Permanente Northern California between 2009 and 2019. Generalized estimating equations and Cochran-Armitage testing were used to assess myomectomy incidence and linear trend in the proportions of myomectomy by surgical route-abdominal myomectomy and minimally invasive myomectomy. Multivariable logistic regression analyses were used to assess the associations between surgical route and (1) race and ethnicity and (2) complications, controlling for patient demographic, clinical, and surgical characteristics. RESULTS: A total of 4033 adult women underwent a myomectomy during the study period. Myomectomy incidence doubled from 0.12 (95% confidence interval, 0.12-0.13) per 1000 women in 2009 to 0.25 (95% confidence interval, 0.24-0.25) per 1000 women in 2019 (P<.001). During the 11-year study period, the proportion of minimally invasive myomectomy increased from 6.0% to 89.5% (a 15-fold increase). The proportion of minimally invasive myomectomy in Black women remained lower than in non-Black women (54.5% vs 64.7%; P<.001). Black women undergoing myomectomy were younger (36.4±5.6 vs 37.4±5.8 years; P<.001), had a higher mean fibroid weight (436.0±505.0 vs 324.7±346.1 g; P<.001), and had a higher mean body mass index (30.8±7.3 vs 26.6±5.9 kg/m2; P<.001) than their non-Black counterparts. In addition to patient race, surgery performed between 2016 and 2019 compared with surgery performed between 2009 and 2012 and higher surgeon volume compared with low surgeon volume were associated with an increased proportion of minimally invasive myomectomy (adjusted relative risks, 12.58 [95% confidence interval, 9.96-15.90] and 6.63 [95% confidence interval, 5.35-8.21], respectively). Black race and fibroid weight of >500 g each independently conferred lower rates of minimally invasive myomectomy. In addition, there was an interaction between race and fibroid weight such that Black women with a fibroid weight of ≤500 g or >500 g were both less likely to have minimally invasive myomectomy than non-Black women with a fibroid weight of ≤500 g (adjusted relative risks, 0.74 [95% confidence interval, 0.58-0.95] and 0.26 [95% confidence interval, 0.18-0.36], respectively). Operative, perioperative, and medical complications were low during the 11-year study period. In regression analyses, after controlling for race, age, fibroid weight, parity, low-income residence, body mass index, surgeon volume, and year of myomectomy, the risk of complications was not markedly different comparing abdominal myomectomy with minimally invasive myomectomy. Similar results were found comparing laparoscopic minimally invasive myomectomy with robotic-assisted minimally invasive myomectomy except for women who underwent laparoscopic minimally invasive myomectomy had a lower risk of experiencing any medical complications than those who underwent robotic-assisted minimally invasive myomectomy (adjusted relative risk, 0.27; 95% confidence interval, 0.09-0.83; P=.02). CONCLUSION: Within an integrated healthcare delivery system, although initiatives to encourage minimally invasive surgery were associated with a marked increase in the proportion of minimally invasive myomectomy, Black women continued to be less likely to undergo minimally invasive myomectomy than their non-Black counterparts. Race and fibroid weight alone did not explain the disparities in minimally invasive myomectomy.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Zaritsky E, Le A, Tucker LY, et al. Minimally invasive myomectomy: practice trends and differences between Black and non-Black women within a large integrated healthcare system. Am J Obstet Gynecol. 2022. PMID: 35101407. doi:10.1016/j.ajog.2022.01.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。